The mechanism of DM2T development involves the presence of insulin resistance resulting from the surplus of free fatty acids and the enhanced production of pro-inflammatory cytokines followed by overproduction of insulin by the pancreas as a compensatory mechanism (initially) to insulin resistance and gradual degeneration of pancreatic β-cells [8]. The gene discussed is INS; the disease is Insulin resistance.